Remdesivir for the Treatment of Covid-19 — Final Report
Our data show that remdesivir was superior to placebo in shortening the time to recovery in adults who were hospitalized with Covid-19 and had evidence of lower respiratory trac...
Publications
2 shownEarly Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients
Among nonhospitalized patients who were at high risk for Covid-19 progression, a 3-day course of remdesivir had an acceptable safety profile and resulted in an 87% lower risk of...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 8,783
- Institution
- University College London
External Links
Identifiers
- ORCID
- 0000-0002-6553-691X
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.